What is the generic name?

LEVOLEUCOVORIN

What is the Trade Name for LEVOLEUCOVORIN?

Fusilev

What are the Indications for LEVOLEUCOVORIN?

• 1 INDICATIONS AND USAGE Fusilev is indicated for: ‚Ä¢ rescue after high-dose methotrexate therapy in adult and pediatric patients with osteosarcoma. ‚Ä¢ diminishing the toxicity associated with overdosage of folic acid antagonists or impaired methotrexate elimination in adult and pediatric patients. ‚Ä¢ the treatment of adults with metastatic colorectal cancer in combination with fluorouracil. Limitations of Use Fusilev is not indicated for pernicious anemia and megaloblastic anemia secondary to the lack of vitamin B 12 , because of the risk of progression of neurologic manifestations despite hematologic remission. Fusilev is a folate analog indicated for: ‚Ä¢ Rescue after high-dose methotrexate therapy in adult and pediatric patients with osteosarcoma. ( 1 ) ‚Ä¢ Diminishing the toxicity associated with overdosage of folic acid antagonists or impaired methotrexate elimination in adult and pediatric patients. ( 1 ) ‚Ä¢ Treatment of adults with metastatic colorectal cancer in combination with fluorouracil. ( 1 ) Limitations of Use: Fusilev is not indicated for the treatment of pernicious anemia and megaloblastic anemia secondary to lack of vitamin B12, because of the risk of progression of neurologic manifestations despite hematologic remission. ( 1 )

References: https://open.fda.gov/